Biopharmaceuticals United States Page 2 - drug manufacturing & research biotechnology

Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors ...

Pipex Pharmaceuticals, Inc. (Pipex) is a development-stage, specialty pharmaceutical company that is developing late-stage drug candidates for the treatment of neurologic and fibrotic diseases. The Company's drug candidates address the pharmaceutical market ...

XTL Biopharmaceuticals Ltd. (XTLbio) is the drug development company committed to conquering hepatitis C in our time. XTLbio's HepeX product line - now in clinical trials - has the potential to introduce revolutionary therapies for viral hepatitis, including ...

Xechem is a biopharmaceutical company engaged in the research, development and production of generic and proprietary drugs from natural sources, specializing in the development of difficult to replicate anticancer, antiviral (including Human Immuno-deficiency ...

We are currently in the process of building a commercial organization to market and sell tetrabenazine in the U.S. upon regulatory approval. Cambridge Laboratories (Ireland), Limited, our licensor for tetrabenazine, has granted us exclusive rights to market ...

A business unit of IDG, Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life science, healthcare, pharmaceutical and regulatory professionals. The company's award-winning publication, Bio-IT World, and accompanying ...

BioMedicines, Inc. is a biopharmaceutical company that acquires and develops drug candidates for which the Company has identified alternative development strategies. The Company has assembled a portfolio of five drug candidates, and it has initiated new ...

Berlex, a U.S. affiliate of Schering AG, Germany (FSE: SCH), is committed to addressing unmet medical needs through research and development in the areas of oncology, gastroenterology, women's health, diagnostics and neurology. Berlex also markets diagnostic ...

SCOLR Pharma, Inc. is a specialty pharmaceutical company. SCOLR is an acronym for Self-Correcting Oral Linear Release, a feature of the Company’s lead technology. The Company’s utilizes its Controlled Delivery Technology (CDT) platform to develop pharmaceutical ...

CEL-SCI Corporation is engaged in the development of a product called Multikine for the treatment of cancer. It simulates the activities of a healthy person's immune system, which battles cancer every day. Multikine is multi-targeted, it is the cancer ...

Inovio Biomedical Corporation (Inovio) is a San Diego-based biomedical company focused on the development of vaccines to prevent or treat cancers and chronic infectious diseases. The Company is a player in developing deoxyribonucleic acid (DNA) delivery ...

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction. Its initial product candidate is CPP-109, which is its version of the chemical ...

Since 1989, BioZone Laboratories, Inc. has operated as a developer, manufacturer, and marketer of over-the-counter drugs and preparations, cosmetics, and nutritional supplements. BioZone has developed hundreds of products throughout its history and sold ...

Napo Pharmaceuticals focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace in collaboration with local partners. Our strategy is to focus both on higher-volume business in the emerging economies of the ...

Alexza Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of acute and intermittent conditions. The Company has six product candidates in clinical development. Its ...

Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE: BAX). Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical ...

Argolyn Bioscience, Inc. is a privately held biopharmaceutical company dedicated to discovering and developing novel peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders. Our most advanced development candidate is ...

Providers of biopharmaceuticals in Cambridge

Ferring aims to further strengthen its position in the coming years through alliances with other pharmaceutical companies and academic institutions. We already have worldwide partnerships with a number of pharmaceutical and biotech companies as well as ...

Active in Life Science markets, the Siegfried Group is a global manufacturer of pharmaceutical products. With production facilities located in Switzerland, Germany, Malta and the United States Siegfried currently has approximately 950 employees and achieved ...

Tigris Pharmaceuticals is a development stage biopharmaceutical company devoted to finding breakthrough therapies for cancer patients. With proven records of the management team in guiding molecules from early stage of clinical development to successful ...

Cognetix is a private drug discovery and development company located in Salt Lake City, Utah, focused on commercializing conopeptide-based pharmaceuticals. Conopeptides are bioactive peptides in the venom of marine cone snails. The Company is currently ...

The Biotechnology Information Institute (BII) develops unique, high-end information resources and provides consulting serving critical needs of the biotechnology and pharmaceutical communities. As a sole proprietorship, Ronald A. Rader, President, is responsible ...

INNOVIVE Pharmaceuticals is a biopharmaceutical company headquartered in midtown Manhattan. Our mission is to acquire, develop and commercialize novel therapeutics addressing significant unmet medical needs in the fields of oncology and hematology.

ACCESS Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and marketing novel therapeutics for cancer and related conditions. ACCESS has built a portfolio of proprietary anti-cancer product candidates through the in-licensing ...